In Friday’s Wall Street session, Ocugen Inc (NASDAQ:OCGN) shares traded at $1.06, up 11.24% from the previous session.
OCGN stock price is now 41.35% away from the 50-day moving average and 25.11% away from the 200-day moving average. The market capitalization of the company currently stands at $309.55M.
With the price target of $4, Maxim Group recently initiated with Buy rating for Ocugen Inc (NASDAQ: OCGN). On March 01, 2023, Chardan Capital Markets Upgraded its previous ‘Neutral’ rating to ‘Buy’ on the stock keeping its target price maintained at $3.50, while ‘Mizuho’ rates the stock as ‘Buy’
In other news, Fernandes Prabhavathi, Director bought 10,000 shares of the company’s stock on Nov 26 ’24. The stock was bought for $9,095 at an average price of $0.91. Upon completion of the transaction, the Director now directly owns 10,000 shares in the company, valued at $10600.0. An SEC document containing details of the transaction can be found on the SEC’s website. On Nov 22 ’24, Director Castillo Kirsten bought 25,000 shares of the business’s stock. A total of $22,848 was incurred on buying the stock at an average price of $0.91. This leaves the insider owning 75,000 shares of the company worth $79500.0. A total of 1.80% of the company’s stock is owned by insiders.
During the past 12 months, Ocugen Inc has had a low of $0.51 and a high of $1.98. As of last week, the company has a debt-to-equity ratio of 2.00, a current ratio of 2.60, and a quick ratio of 2.60.
The net profit margin was -1160.86% and return on equity was -248.97% for OCGN. The company reported revenue of $1.48 million for the quarter, compared to $1.01 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 46.06 percent.
